Former Indivior CEO Pleads Guilty in U.S. in Opioid Addiction Treatment Probe

REUTERS

Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone.

Thaxter pleaded guilty in federal court in Abingdon, Virginia to a misdemeanor count of introducing misbranded drugs into interstate commerce. The plea came a day after Indivior said he was stepping down as CEO.

Prosecutors said Thaxter failed to prevent employees from sharing misleading safety information about the drug with Massachusetts' Medicaid program as it considered expanding coverage for it. read more »

Police raid Wirecard HQ as administrator kicks off asset sales

REUTERS

Police and public prosecutors raided Wirecard’s headquarters in Munich and four properties in German and Austria on Wednesday as they widened their investigation into the financial payments company that collapsed last week.

Wirecard filed for insolvency last week owing creditors almost $4 billion after disclosing a 1.9 billion euro ($2.1 billion) hole in its accounts that its auditor EY said was the result of a sophisticated global fraud. read more »

Fifth Pharmaceutical Company Charged In Ongoing Criminal Antitrust Investigation

DOJ

Glenmark Pharmaceuticals Inc., USA was charged for conspiring to fix prices for generic drugs, the Department of Justice announced today.

The charge, filed today in the U.S. District Court in Philadelphia, Pennsylvania, alleges that Glenmark conspired with other generic drug companies, including a company with its principal place of business in Montgomery County, Pennsylvania, and Apotex Corp., to increase and maintain prices of pravastatin and other generic drugs

Glenmark is the fifth company to be charged over the last 13 months in connection with antitrust violations in the generic pharmaceutical industry. read more »